Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.51 USD | +0.23% | -1.13% | -0.85% |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 4.79B | 3.12B | 4.09B | 4.22B | 4.31B | |||||
Total Revenues | 4.79B | 3.12B | 4.09B | 4.22B | 4.31B | |||||
Cost of Goods Sold, Total | 2.89B | 1.98B | 2.13B | 2.22B | 2.2B | |||||
Gross Profit | 1.9B | 1.14B | 1.96B | 2B | 2.11B | |||||
Selling General & Admin Expenses, Total | 887M | 707M | 810M | 814M | 834M | |||||
R&D Expenses | 266M | 191M | 238M | 255M | 234M | |||||
Depreciation & Amortization - (IS) | - | - | - | - | - | |||||
Amortization of Goodwill and Intangible Assets - (IS) | - | - | - | - | - | |||||
Other Operating Expenses | - | 4.33M | 1M | 4M | - | |||||
Other Operating Expenses, Total | 1.15B | 902M | 1.05B | 1.07B | 1.07B | |||||
Operating Income | 744M | 234M | 909M | 927M | 1.04B | |||||
Interest Expense, Total | -423M | -418M | -360M | -302M | -310M | |||||
Interest And Investment Income | 13.29M | 14.96M | 13M | 13M | 25M | |||||
Net Interest Expenses | -410M | -403M | -347M | -289M | -285M | |||||
Income (Loss) On Equity Invest. | - | - | - | - | - | |||||
Currency Exchange Gains (Loss) | 39.84M | -309M | 66M | -36M | -75M | |||||
Other Non Operating Income (Expenses) | -9.61M | -5.16M | -6M | -2M | -8M | |||||
EBT, Excl. Unusual Items | 365M | -483M | 622M | 600M | 671M | |||||
Restructuring Charges | -24.86M | -45.04M | -6M | -6M | -37M | |||||
Merger & Related Restructuring Charges | - | - | - | - | - | |||||
Impairment of Goodwill | -99M | -296M | - | - | - | |||||
Gain (Loss) On Sale Of Investments | 33.88M | - | - | - | - | |||||
Gain (Loss) On Sale Of Assets | 27.7M | - | - | 278M | - | |||||
Asset Writedown | -994K | - | - | - | - | |||||
Legal Settlements | -4.6M | - | - | -270M | - | |||||
Other Unusual Items | -11.94M | -23.26M | -87M | -13M | -5M | |||||
EBT, Incl. Unusual Items | 285M | -848M | 529M | 589M | 629M | |||||
Income Tax Expense | 173M | 27.7M | 274M | 175M | 322M | |||||
Earnings From Continuing Operations | 112M | -875M | 255M | 414M | 307M | |||||
Earnings Of Discontinued Operations | - | 41.44M | 417M | - | - | |||||
Net Income to Company | 112M | -834M | 672M | 414M | 307M | |||||
Minority Interest | -131M | -63.93M | -190M | -139M | -151M | |||||
Net Income - (IS) | -19.02M | -898M | 482M | 275M | 156M | |||||
Net Income to Common Incl Extra Items | -19.02M | -898M | 482M | 275M | 156M | |||||
Net Income to Common Excl. Extra Items | -19.02M | -939M | 65M | 275M | 156M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | -0.09 | -4.39 | 2.35 | 1.36 | 0.78 | |||||
Basic EPS - Continuing Operations | -0.09 | -4.59 | 0.32 | 1.36 | 0.78 | |||||
Basic Weighted Average Shares Outstanding | 204M | 205M | 205M | 202M | 200M | |||||
Net EPS - Diluted | -0.09 | -4.39 | 2.33 | 1.35 | 0.77 | |||||
Diluted EPS - Continuing Operations | -0.09 | -4.59 | 0.31 | 1.35 | 0.77 | |||||
Diluted Weighted Average Shares Outstanding | 204M | 205M | 207M | 203M | 203M | |||||
Normalized Basic EPS | 0.48 | -1.79 | 0.97 | 1.17 | 1.34 | |||||
Normalized Diluted EPS | 0.48 | -1.79 | 0.96 | 1.16 | 1.32 | |||||
Dividend Per Share | 0.8 | 0.2 | 0.2 | 0.8 | 0.8 | |||||
Payout Ratio | -859.41 | -4.55 | 8.51 | 58.55 | 102.56 | |||||
American Depositary Receipts Ratio (ADR) | 1 | 1 | 1 | 1 | 1 | |||||
Supplemental Items | ||||||||||
EBITDA | 1.43B | 774M | 1.41B | 1.4B | 1.54B | |||||
EBITA | 994M | 419M | 1.09B | 1.1B | 1.24B | |||||
EBIT | 744M | 234M | 909M | 927M | 1.04B | |||||
EBITDAR | 1.59B | 869M | 1.51B | 1.48B | 1.62B | |||||
Total Revenues (As Reported) | 4.79B | 3.12B | 4.09B | 4.22B | 4.31B | |||||
Effective Tax Rate - (Ratio) | 60.79 | -3.27 | 51.8 | 29.71 | 51.19 | |||||
Current Domestic Taxes | 1.8M | -819K | - | 3M | 7M | |||||
Current Foreign Taxes | 240M | 107M | 236M | 248M | 294M | |||||
Total Current Taxes | 241M | 106M | 236M | 251M | 301M | |||||
Deferred Domestic Taxes | -78K | -190K | - | - | - | |||||
Deferred Foreign Taxes | -68.22M | -78.28M | 38M | -77M | 22M | |||||
Total Deferred Taxes | -68.29M | -78.47M | 38M | -77M | 22M | |||||
Normalized Net Income | 97.18M | -366M | 199M | 236M | 268M | |||||
Interest Capitalized | - | - | - | - | - | |||||
Interest on Long-Term Debt | 418M | 414M | 324M | 296M | 300M | |||||
Non-Cash Pension Expense | - | - | - | - | - | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 41.4M | 25M | - | - | - | |||||
Selling and Marketing Expenses | 41.4M | - | - | - | - | |||||
Research And Development Expense From Footnotes | 266M | 191M | 238M | 255M | 234M | |||||
Net Rental Expense, Total | 158M | 94.61M | 94M | 85M | 84M | |||||
Imputed Operating Lease Interest Expense | 64.83M | 37.15M | 34.99M | 31.81M | 34.71M | |||||
Imputed Operating Lease Depreciation | 93.47M | 57.47M | 59.01M | 53.19M | 49.29M | |||||
Stock-Based Comp., COGS (Total) | 2.56M | -1.42M | 2M | 2M | 2M | |||||
Stock-Based Comp., R&D Exp. (Total) | 2.54M | -1.3M | 3M | 2M | 2M | |||||
Stock-Based Comp., SG&A Exp. (Total) | 21.41M | -4.16M | 30M | 37M | 38M | |||||
Stock-Based Comp., Other (Total) | - | - | - | - | - | |||||
Total Stock-Based Compensation | 26.51M | -6.88M | 35M | 41M | 42M |